Literature DB >> 12127173

Substance use for insomnia in Metropolitan Detroit.

Timothy Roehrs1, Emily Hollebeek, Christopher Drake, Thomas Roth.   

Abstract

OBJECTIVE: People with insomnia are not typically treated medically for their insomnia. Studies have reported approximately 30% of insomniacs self-medicate with alcohol or over-the-counter (OTC) medications. This study was done to identify determinants and risks of different insomnia therapeutics.
METHODS: A random-digit-dial, computer-assisted survey of a representative sample of adults in Metropolitan Detroit, aged 18-65 years, is being conducted. A sample of all respondents over an 18-month period was collected (n=1324) with a 68% response rate. Exclusive past-year use of alcohol for sleep was reported by 10% (n=132), prescription medications by 8% (n=108), and OTC medications by 10% (n=135). Five percent used both alcohol and sleep medications. The three exclusive-use groups formed the comparison groups of the study.
RESULTS: The prescription drug group used medications for more consecutive nights and for more total nights than the alcohol and OTC users. Alcohol users were predominantly male, while OTC and prescription drug users were predominantly female. Alcohol users were more likely to be single than the others, and prescription drug users were older than the others. Prescription drug users had more severe insomnia and had greater disability, neuroticism, and daytime fatigue than the others. In contrast, the alcohol users had greater daytime sleepiness than the others.
CONCLUSIONS: In Metropolitan Detroit, insomniacs receiving medical treatment have more severe insomnia and greater disability than those who self-treat. However, while the insomnia of those self-treating is less severe, it is still associated with some risks.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127173     DOI: 10.1016/s0022-3999(02)00448-8

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  11 in total

1.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Cognitive prescriptions.

Authors:  David E Vance; Greg Eagerton; Brenna Harnish; Peggy McKie; Pariya L Fazeli
Journal:  J Gerontol Nurs       Date:  2010-12-22       Impact factor: 1.254

3.  Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.

Authors:  Timothy A Roehrs; Surilla Randall; Erica Harris; Renee Maan; Thomas Roth
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

Review 4.  Insomnia pharmacotherapy.

Authors:  Timothy Roehrs; Thomas Roth
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

5.  Association of hypnotics with stroke risk: a population-based case-control study.

Authors:  Ching-Chih Lee; Kuan-Yi Tsai; Yeh-Ting Hung; Frank Huang-Chih Chou; Yung-Sung Huang
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-27

6.  Life-time history of insomnia and hypersomnia symptoms as correlates of alcohol, cocaine and heroin use and relapse among adults seeking substance use treatment in the United States from 1991 to 1994.

Authors:  Michael R Dolsen; Allison G Harvey
Journal:  Addiction       Date:  2017-02-28       Impact factor: 6.526

Review 7.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  How disturbed sleep may be a risk factor for adverse pregnancy outcomes.

Authors:  Michele L Okun; James M Roberts; Anna L Marsland; Martica Hall
Journal:  Obstet Gynecol Surv       Date:  2009-04       Impact factor: 2.347

9.  Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis.

Authors:  Alyssa M Bamer; Kurt L Johnson; Dagmar A Amtmann; George H Kraft
Journal:  Clin Epidemiol       Date:  2010-05-01       Impact factor: 4.790

Review 10.  Does effective management of sleep disorders reduce substance dependence?

Authors:  Thomas Roth
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.